ductal carcinoma in situ
DCIS Risk Biomarker on the Horizon
Researchers have completed the first of three planned validation studies for PreludeDx. The tool is designed to ...
MARCH 15, 2017
Better Prognostic Tools Are Needed for DCIS
In recent years, controversy has swirled around the treatment of ductal carcinoma in situ (DCIS). At the 2015 San ...
APRIL 11, 2016
Load more